Company

Recursion

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

Decoding biology to radically improve lives

Also known as RECURSION PHARMACEUTICALS, INC.

Biotech & therapeutics
AI native

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: Salt Lake City, UT, United States
Customers: leading biopharmaceutical and technology companies
Legal name: RECURSION PHARMACEUTICALS, INC.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

We’re using data and AI to bring better medicines to patients, faster.

Funding snapshot

Total raised: $478MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $246M2020-09-01

Funding rounds

Round, 2020: $246M2020-09-01, SEC form D sold, 49 investors
Round, 2019: $122M2019-02-12, SEC form D sold, 33 investors
Round, 2017: $55.8M2017-09-25, SEC form D sold, 26 investors
Round, 2016: $15M2016-09-02, SEC form D sold, 18 investors
Round, 2016: $4.1M2016-09-01, SEC form D sold, 31 investors
Round, 2016: $32M2016-09-01, SEC form D sold, 32 investors
Round, 2015: $2.6M2015-11-20, SEC form D sold, 8 investors
Round, 2015: $830K2015-02-17, SEC form D sold, 19 investors
Round, 2014: $80K2014-03-19, SEC form D sold, 5 investors

Products

Other: Recursion OS